Notícias do Mercado de Ações

Últimas notícias financeiras · Atualizado Mai 23, 2026

▬ mixed

Jim Cramer Diz “Target Tem Sido um Destaque”

Jim Cramer Says “Target Has Been a Standout”

Despite a strong YTD performance and Q4 earnings beat, panelists express caution due to lingering negative comparable store sales, heavy …

Yahoo Finance · Mar 25, 2026
WMT
▬ mixed

Jim Cramer Diz Que Varejistas Como Walmart Se Desempenhariam Bem Se Pensarmos Que Estamos Caminhando Para Uma Desaceleração Devido Aos Preços Do Petróleo

Jim Cramer Says Retailers Like Walmart Would “Do Well If You Think That We’re Headed Toward a Slowdown Because of Oil Prices”

The panelists agreed that Walmart's (WMT) defensive positioning in an oil-price-driven slowdown is credible, but its high valuation (around 28x …

Yahoo Finance · Mar 25, 2026
FIVE
▬ mixed

Jim Cramer sobre Five Below: “Acho que continua forte”

Jim Cramer on Five Below: “I Think It’s Staying Strong”

The panelists' views on Five Below (FIVE) are mixed, with concerns about the company's 'identity crisis', valuation, and rising costs …

Yahoo Finance · Mar 25, 2026
SPY UAL VIX
▼ bear…

O S&P 500 Salta 1% Impulsionado pela Esperança de Negociações de Paz com o Irã e o Petróleo Cai Abaixo da Marca Crítica de US$ 100 o Barril

The S&P 500 Rips 1% Higher On Hope For Iran Peace Negotiations and Oil Falls Below Critical $100 Barrel Line

The panel agrees that the current rally in markets is built on fragile geopolitical sentiment and is likely to reverse …

Yahoo Finance · Mar 25, 2026
ROST
▬ mixed

Jim Cramer sobre Ross Stores: “Esse Último Trimestre Mostrou Mais Força do Que Eu Vi Nessa Empresa em Anos”

Jim Cramer on Ross Stores: “That Last Quarter Showed More Strength Than I’ve Seen From That Company in Ages”

Panelists are divided on Ross Stores (ROST) with valid points on both sides. Bulls highlight strong Q3 results, Gen Z …

Yahoo Finance · Mar 25, 2026
TACO
▬ mixed

TACO Vs TAW: Desfazer Este Rali (de Ações)

TACO Vs TAW: Fade This (Equity) Rally

The panel is divided on the impact of a potential 30-day ceasefire. While some argue it could lead to a …

ZeroHedge · Mar 25, 2026
▬ mixed

Jim Cramer Destaca Que a TJX Companies Está "Ganhando Muito Dinheiro Ao Adquirir Estoque Excedente de Varejistas em Dificuldades"

Jim Cramer Highlights TJX Companies Are “Making a Killing By Scooping Up Excess Inventory From Troubled Retailers”

The panelists generally agree that TJX (NYSE:TJX) has benefited from distressed inventory and is well-positioned in a bifurcated retail landscape, …

Yahoo Finance · Mar 25, 2026
▬ mixed

Jim Cramer Diz que a Retração em Jacobs Solutions Não Faz Sentido para Ele

Jim Cramer Says the Pullback in Jacobs Solutions Makes No Sense to Him

Panelists have mixed views on Jacobs (J), with concerns about the upcoming spin-off, data center capex cycles, and execution risks, …

Yahoo Finance · Mar 25, 2026
ULTA
▬ mixed

Jim Cramer destaca Ulta Beauty por suas fortes vendas de produtos de alta gama, apesar de um recente desempenho abaixo do esperado nos lucros.

Jim Cramer Highlights Ulta Beauty For Its Strong High End Sales Despite A Recent Earnings Miss

The panel is divided on Ulta Beauty's (ULTA) outlook, with concerns about structural margin pressure, competition from Sephora at Kohl's, …

Yahoo Finance · Mar 25, 2026
▬ mixed

Jim Cramer sobre Swarmer, Inc.: “Vamos Chamá-la de uma História Legal, Mas Nada Mais do Que Isso”

Jim Cramer on Swarmer, Inc.: “Let’s Call It a Cool Story, But Not Much More Than That”

The panel consensus is that Swarmer (SWMR) is overhyped and lacks fundamentals, with barely any revenue and high annual losses. …

Yahoo Finance · Mar 25, 2026
NVDA
▬ mixed

SLB expande parceria com Nvidia para desenvolver infraestrutura de IA para o setor de energia

SLB expands Nvidia partnership to develop AI infrastructure for energy sector

The panel is mixed on SLB's pivot into AI infrastructure design. While some see high-margin opportunities and diversification away from …

Yahoo Finance · Mar 25, 2026
TERN
▬ mixed

Ações da Terns Pharmaceuticals sobem 5% com acordo de aquisição pela Merck

Terns Pharmaceuticals Stock Gains 5% Over Acquisition Deal With Merck

The panel is uncertain about Merck's acquisition of Terns Pharmaceuticals due to lack of clinical details on TERN-701's efficacy and …

Nasdaq · Mar 25, 2026